奧拓電子(002587.SZ):已交付數個國有大型銀行的虛擬數字人項目
格隆匯3月15日丨奧拓電子(002587.SZ)在接受特定機構調研時表示,虛擬數字人是公司控股子公司創想數維核心業務之一。目前主要為銀行等領域客户提供定製化虛擬數字人服務,已交付了數個國有大型銀行的虛擬數字人項目,獲得了客户的一致好評;攜手某國有大型銀行為其在第五屆數字中國建設峯會上打造了虛擬數字經理,助力傳統金融模式的數字化重構。今年也將與一些文化影視、MCN機構共同探索數字人IP孵化及運營的業務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.